Skip to content

Avanos Medical AVNS Raw materials

Raw materials at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
Baxter International logo
Baxter InternationalBAX
Globus Medical logo
Globus MedicalGMED
Enovis logo
EnovisENOV

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:InventoryRawMaterials.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's raw materials.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's raw materials?
Avanos Medical (AVNS) reported raw materials of $34.1M in Q1 2026.
How has Avanos Medical's raw materials changed year-over-year?
Avanos Medical's raw materials decreased by 8.8% year-over-year, from $37.4M to $34.1M.
What is the long-term trend for Avanos Medical's raw materials?
Over 5 years (2020 to 2025), Avanos Medical's raw materials has grown at a -5.9% compound annual growth rate (CAGR), from $47M to $34.7M.